Related references
Note: Only part of the references are listed.Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases
David W. Crabb et al.
HEPATOLOGY (2020)
Alcoholic Liver Disease Epidemiology in the United States: A Retrospective Analysis of 3 US Databases
Katherine Dang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK
Roger Williams et al.
LANCET (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Sadaf G. Sepanlou et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Global Epidemiology of Viral Hepatitis
Homie Razavi
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2020)
Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?
Adam Palayew et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Comparison of MAFLD and NAFLD diagnostic criteria in real world
Su Lin et al.
LIVER INTERNATIONAL (2020)
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Theo Vos et al.
LANCET (2020)
Comprehensive Health-State Utilities in Contemporary Patients With Cirrhosis
Chelsey Foster et al.
HEPATOLOGY COMMUNICATIONS (2020)
Increasing Economic Burden in Hospitalized Patients With Cirrhosis: Analysis of a National Database
Archita P. Desai et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)
Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life
Zobair M. Younossi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Immediate impact of minimum unit pricing on alcohol purchases in Scotland: controlled interrupted time series analysis for 2015-18
Amy O'Donnell et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Non-alcoholic fatty liver disease - A global public health perspective
Zobair M. Younossi
JOURNAL OF HEPATOLOGY (2019)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real-World Data From a Large US Claims Database
Alina M. Allen et al.
HEPATOLOGY (2018)
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes et al.
JOURNAL OF HEPATOLOGY (2018)
Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies
Laura Pimpin et al.
JOURNAL OF HEPATOLOGY (2018)
Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Max G. Griswold et al.
LANCET (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Hmwe Hmwe Kyu et al.
LANCET (2018)
Declining mortality in critically ill patients with cirrhosis in Australia and New Zealand between 2000 and 2015
Avik Majumdar et al.
JOURNAL OF HEPATOLOGY (2017)
Time trends of chronic HBV infection over prior decades - A global analysis
Joerdis J. Ott et al.
JOURNAL OF HEPATOLOGY (2017)
A rapid evidence review of the effectiveness and cost-effectiveness of alcohol control policies: an English perspective
Robyn Burton et al.
LANCET (2017)
Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013 Results From the National Epidemiologic Survey on Alcohol and Related Conditions
Bridget F. Grant et al.
JAMA PSYCHIATRY (2017)
Direct and Indirect Economic Burden of Chronic Liver Disease in the United States
Maria Stepanova et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
The cost-effectiveness of daclatasvir-based regimens for the treatment of hepatitis C virus genotypes 1 and 4 in the UK
Phil McEwan et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Decreasing Mortality Among Danish Alcoholic Cirrhosis Patients: A Nationwide Cohort Study
Thomas Deleuran et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Treatment of alcohol use disorders in patients with alcoholic liver disease
Giovanni Addolorato et al.
JOURNAL OF HEPATOLOGY (2016)
The patient's journey with chronic hepatitis C from interferon plus ribavirin to interferon- and ribavirin-free regimens: a study of health-related quality of life
Z. M. Younossi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Decreasing Mortality Among Patients Hospitalized With Cirrhosis in the United States From 2002 Through 2010
Monica L. Schmidt et al.
GASTROENTEROLOGY (2015)
Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2015)
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III
Bridget F. Grant et al.
JAMA PSYCHIATRY (2015)
Disability weights for the Global Burden of Disease 2013 study
Joshua A. Salomon et al.
LANCET GLOBAL HEALTH (2015)
1 and 5 year survival estimates for people with cirrhosis of the liver in England, 1998-2009: A large population study
Sonia Ratib et al.
JOURNAL OF HEPATOLOGY (2014)
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis
Roger Williams et al.
LANCET (2014)
Feasibility of detection and intervention for alcohol-related liver disease in the community: the Alcohol and Liver Disease Detection study (ALDDeS)
N. Sheron et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2013)
Acceptability of screening for early detection of liver disease in hazardous/harmful drinkers in primary care
Caroline Eyles et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2013)
Incidence, etiology and mortality of cirrhosis: a population-based cohort study
Annette Dam Fialla et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis
J. Thompson Coon et al.
BRITISH JOURNAL OF CANCER (2008)
Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: A general population-based study
Kate M. Fleming et al.
JOURNAL OF HEPATOLOGY (2008)
Factors associated with poor health-related quality of life of patients with cirrhosis
G Marchesini et al.
GASTROENTEROLOGY (2001)
Share Paper
